# West Pharmaceutical Services, Inc. – Consensus ‘buy’ rating and 1.5% Upside Potential

- Link: https://www.directorstalkinterviews.com/west-pharmaceutical-services-inc.consensus-buy-rating-and-1.5-upside-potential/4121127870
- Published: 2023-09-20T15:17:10+01:00
- Author: Charlotte Edwards

**West Pharmaceutical Services, Inc.** which can be found using ticker (WST) have
now 7 confirmed analysts covering the stock with the consensus suggesting a rating
of ‘buy’. The target price High/Low ranges between 460 and 325 and has a mean target
at $400.71. Given that the stocks previous close was at $394.60 this would indicate
that there is a potential upside of 1.5%. There is a 50 day moving average of $389.49
and the 200 moving average now moves to $332.96. The market capitalization for the
company is 29.00B. The current share price for the company is: 392.61 USD

 The potential market cap would be $29,447,659,711 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 57.23, revenue per share of 38.52
and a 12.49% return on assets.

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the
design and production of technologically advanced, integrated containment and delivery
systems for injectable drugs and healthcare products. The Company operates through
two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary
Products segment offers proprietary packaging, containment solutions, and drug delivery
products, along with analytical lab services and other integrated services and solutions,
primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured
Products segment serves as a fully integrated business, focused on the design, manufacture,
and automated assembly of complex devices, primarily for pharmaceutical, diagnostic,
and medical device customers. This segment manufactures customer-owned components
and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug
delivery systems, as well as consumer products.

Share on: